Elara Pharmaceuticals
Elara Pharmaceuticals's alternatives and competitors
See how Elara Pharmaceuticals compares to similar products. Elara Pharmaceuticals's top competitors include Kythera Biopharmaceuticals, Idenix Pharmaceuticals, and ugichem.
Kythera (NASDAQ: KYTH) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the …
View more in-depth data on:
- Competitors
- Products
- Customer References and more
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Idenix Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix is headquarter…
Elara Pharmaceuticals vs. Idenix PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
- UG
ugichem is developing antisense drugs based on its proprietary Ugimer platform for unmet medical needs in immune-mediated inflammatory diseases (IMID). Ugimers overcome…
Elara Pharmaceuticals vs. ugichemView more in-depth data on:
- Competitors
- Products
- Customer References and more
Callisto Pharmaceuticals is a biopharmaceutical company focused on the development of drugs to treat multiple myeloma (an incurable blood cancer that invades and prolif…
Elara Pharmaceuticals vs. Callisto PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
Excaliard Pharmaceuticals is a biopharmaceutical company focused on developing drugs for the local treatment of fibrosis, including skin scarring.
Elara Pharmaceuticals vs. Excaliard PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
Arresto Biosciences operates as a biotech company. It develops medicines to treat cancer and fibrotic diseases by targeting extracellular matrix proteins. It offers sol…
Elara Pharmaceuticals vs. Arresto BioSciencesView more in-depth data on:
- Competitors
- Products
- Customer References and more
Affectis Pharmaceuticals, fka neuronova, is a biopharmaceutical company developing drugs for the treatment of psychiatric and inflammatory disorders.
Elara Pharmaceuticals vs. Affectis PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
Altair Therapeutics is a biotechnology company focused on the discovery, development and commercialization of antisense drugs for respiratory conditions.
Elara Pharmaceuticals vs. Altair TherapeuticsView more in-depth data on:
- Competitors
- Products
- Customer References and more
ERA Biotech is a company focused on biotechnology. The company offers a range of technologies for protein engineering, gene therapy, and vaccine development. These tech…
Elara Pharmaceuticals vs. ERA BiotechView more in-depth data on:
- Competitors
- Products
- Customer References and more
Memory Pharmaceuticals is a publicly-traded biopharmaceutical company, focuses on developing drugs for the treatment of CNS disorders such as Alzheimer's disease, schiz…
Elara Pharmaceuticals vs. Memory PharmaceuticalsView more in-depth data on:
- Competitors
- Products
- Customer References and more
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Elara Pharmaceuticals to Competitors
Inflazyme Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of therapies for the treatment of respiratory and inflammatory diseases. The company's core focus is medicinal chemistry based, orally active, small molecules aimed at treating unmet medical needs.
Longevica is a biotechnology that is researching mechanisms of healthy aging and life extension. The company is also developing an open research tool for scientists and research institutions to access a data set that tracks the effects of pharmacological compounds for testing drugs.
Affibody is a private clinical-stage biotech company. It specializes in the discovery of antibody mimetics that provide biodistribution flexibility, tissue penetration, and tumor targeting. The company was founded in 1998 and is based in Solna, Sweden.
Sound Pharmaceuticals (SPI) is a biopharmaceutical company that develops prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans. It was founded in 2002 and is based in Seattle, Washington.
BIKAM Pharmaceuticals, Inc. is an early stage biopharmaceutical company focusing upon the discovery and development of small molecule therapeutics for the treatment of ophthalmic diseases and disorders, including retinitis pigmentosa. Worldwide, there are approximately 1.5 million people which suffer from retinitis pigmentosa (RP), a hereditary disease which leads to blindness. As its initial priority, the company is pursuing the discovery of compounds based on a novel mechanism of action identified by the company's founder, Dr. Shalesh Kaushal. BIKAM has an experienced management team with a strong track record in pharmaceutical drug discovery dedicated to expanding these findings and others from the Kaushal lab to create potential therapeutics to prevent blindness.
greenovation Biotech GmbH is engaged in the production of pharmaceutically highly-efficient glycoproteins
Loading...